New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology careiMDx sponsoring GraftAssureIQ research-use-only kits at transplant labs globallyExhibitin ...

In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more ...

Natera, Inc. shows strong revenue growth with Medicare-backed Signatera, but faces litigation risks and valuation challenges.

Studying the chemical signatures of DNA fragments in the blood could help scientists pinpoint the cause of organ damage ...

According to a new study by Renub Research, the United States Non-Invasive Prenatal Testing Market is set to experience ...

Novartis Canada is pleased to announce the winners of the 2025 Novartis Oncology Young Canadian Investigator Awards (NOYCIA), ...

In an interview with Targeted OncologyTM, Massimo Cristofanilli, MD, medical oncologist at the Breast Center at Weill Cornell ...

The researchers found that cervical mucus from Pap smears has a higher cell-free DNA yield than plasma in endometrial cancer cases.

Scientists in China have developed a new blood test that can find many types of cancer early, with impressive accuracy. This test, created by researchers from Geneseeq and several major hospitals, ...

Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad range of cancers with high accuracy using cell-free DNA. A multi-cancer early ...